ISL1 and neuroendocrine neoplasm: Subsequently, ISL1 expression has also been reported as a highly sensitive marker also for additional neuroendocrine neoplasms, such as Merkel cell carcinomas, pheochromocytomas, paragangliomas, and medullary thyroid carcinomas [9].